Current status: 834 hESC lines, 3229 hiPSC lines, and 99 clinical studies, and 432 certificates
Monthly statistic from Aug 1, 2022
Posted on August 1, 2022
| total lines | 4063 |
| hESC lines | 834 |
| hiPSC lines | 3229 |
| derivation countries | 43 |
| projects | 244 |
| providers | 740 |
| clinical studies | 99 |
| subclones | 1644 |
| certificates | 432 |
| cell line certificates | 308 |
| project certificates | 124 |